Status:
UNKNOWN
Pain Perception in Alzheimer's Disease
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Dementia Alzheimer Type
Eligibility:
All Genders
55-95 years
Brief Summary
The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nerv...
Eligibility Criteria
Inclusion
- \- Clinical diagnosis of Alzheimer's disease Must be able to understand a simple pain scale
Exclusion
- Neuropathy Psychotropic drugs use -
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00192816
Start Date
June 1 2005
Last Update
September 19 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurocognitive unit,Neurophysiology laborator Rambam Health Care Campus
Haifa, Israel, 31096